![Mayo Clinic Talks artwork](https://is3-ssl.mzstatic.com/image/thumb/Podcasts123/v4/fd/bf/1d/fdbf1d0a-130c-d6ed-7d6b-a92df2afdffe/mza_2418082656623755556.jpg/100x100bb.jpg)
Mayo Clinic Q&A - Serology Testing for SARS-CoV-2 Antibodies
Mayo Clinic Talks
English - April 20, 2020 13:41 - 10 minutes - 10.1 MB - ★★★★ - 90 ratingsScience Health & Fitness Medicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
This episode is shared from Mayo Clinic Q&A and was recorded April 2020.
Guest: Elitza S. Theel, Ph.D.
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
A new serology test from Mayo Clinic Laboratories is being used to identify the presence of immune response to SARS-CoV-2, the virus that causes COVID-19. The serology test is intended only to detect antibodies to the virus. It does not diagnose recent or active infection. Mayo Clinic Laboratories also offers a molecular test to diagnose very recent or active infection. Both tests are important tools in the pandemic response.
On the Mayo Clinic Q&A podcast, Dr. Elitza Theel, director of Mayo Clinic’s Infectious Diseases Serology Laboratory, explains why serology testing is initially focused on identifying people in areas where potential immunity is key, including front-line health care workers.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.